DiabetesBe a Leader in Research and Practice

Explore all the ways we support research and practice - including the recently published Hypoglycemia Blueprint, Diabetes Technology Practice Guideline, and research on reducing cardiovascular disease in diabetes.

Five-Year Results of STAMPEDE Trial Show Bariatric Surgery’s Efficacy on Treating T2D
March 2017 | Researchers at Cleveland Clinic last month published the five-year results of STAMPEDE, a groundbreaking trial that compared intensive medical treatment and surgical treatment of uncontrolled type 2 diabetes (T2D). The results…

In Concert: Treating Diabetes & Heart Disease
January 2017 | Cardiovascular disease (CVD) is the leading cause of death for men and women of most ethnicities in the U.S., and one of the main risk factors for CVD is diabetes…

Type 1 Diabetes Linked to Gut Inflammation Bacteria Changes
January 19, 2017 | People with Type 1 diabetes exhibit inflammation in the digestive tract and gut bacteria­—a pattern that differs from individuals who do not have diabetes or those who have celiac disease, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism

Endocrine Society Calls for Solutions Regarding Insulin Price Crisis
December 07, 2016 | The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain…

I’m Still Here: Diabetes & The Aging Patient
December 2016 | As diabetes patients are living longer, endocrinologists are finding themselves faced with a unique set of treatment challenges not often found in younger patients. From cognitive function to…

Low Blood Glucose Levels in Hospitalized Patients Linked to Increased Mortality Risk
November 17, 2016 | In hospitalized patients, low blood sugar—also known as hypoglycemia—is associated with increased short- and long-term mortality risk, according to a new study published in the Endocrine Society’s…

Hypoglycemia: A Comprehensive Approach in the US
November 2016 | The Endocrine Society leads effort to reduce the incidence of hypoglycemia by developing a comprehensive blueprint with diabetes stakeholders recommending actions for how the community can affect…

Diabetes and Bones: An Underappreciated Complication
November 2016 | Diabetes can be weakening the skeleton despite apparently good bone mineral density scores. Fortunately, standard osteoporosis treatments appear to be just as successful in patients with diabetes…

Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
ENDO Satellite Symposium | 2.5 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Chair: Bernard Zinman, MD
Faculty: Naveed Sattar, PhD, FRCP; Hertzel C Gerstein, MD; and Silvio E Inzucchi, MD
Identify cardiovascular risk factors and develop strategies to reduce risks in patients with diabetes using new insights and outcomes data.

The Effective Use of Insulin in Type 2 Diabetes: A Focus on Treatment Advances
ENDO Satellite Symposium | 2.5 AMA PRA Category 1 Credits™
Chair: John (Jack) L. Leahy, MD
Faculty: Lawrence Blonde, MD; Marie E. McDonnell, MD; and Janet B. McGill, MD
How well do you know about the latest insulin options? Keep up to date on advances and algorithms.

New Options and Combinations in Diabetes Management: Optimizing Control and Individualizing Treatment
ENDO Satellite Symposium | 2.0 AMA PRA Category 1 Credits™
Chair: Anne L. Peters, MD
Faculty: Carol H. Wysham, MD; David M. Kayne, MD; and Janet B. McGill, MD
Use new options in GLP-1 receptor agonists, basal insulins, and combinations therein to improve patient outcomes.

Epigenetic Changes in Patients with Type 2 Diabetes and Impact on Insulin Secretion and Action
ENDO Session | No credit available
Charlotte Ling, PhD
Learn about recent discoveries in potential epigenetic contributions to the development and progression of type 2 diabetes.

Transitions of Care: Type 1 Diabetes
Practice Resource | No credit available
Find resources for you and your patients to facilitate the challenging transition from pediatric to adult endocrine practice.

Endocrine Fellows Series: Type 1 Diabetes Care and Management 2016
Fellows Workshop Webcast | 15.0 AMA PRA Category 1 Credits™
Program Directors: Irl B. Hirsch, MD and Linda Siminerio, PhD
Engage in a comprehensive program for pediatric and adult endocrine fellows including foundation education, practice management strategies, and practical approaches to challenging cases.

Diabetes Diagnosis & Management 2016
Workshop Webcast | 8.25 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Planning Chairs: Johns (Jack) L. Leahy, MD; Jane E. B. Reusch, MD; and Carol H. Wysham, MD
Expert faculty provide state-of-the-art updates on cardiometabolic co-morbidities, new treatment options, and day-to-day strategies to manage patients with diabetes.

Endocrine Facts & Figures: Diabetes
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on the common types of diabetes and related conditions with current citations and expert insights.

The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects
JCEM | December 01, 2016
Yeqing Gu, Huihui Li, Xue Bao, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Huanmin Du, Hongbin Shi, Yang Xia, Qian Su, Liyun Fang, Fei Yu, Huijun Yang, Bin Yu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Qi Guo, Hong Chang, Guolin Wang, Guowei Huang, Kun Song, and Kaijun Niu
Type 2 diabetes mellitus (T2DM) is the most common chronic endocrine disease, characterized by hyperglycemia resulting from impaired insulin secretion…

Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study
JCEM | November 23, 2016
Emma Hamilton, Wendy A. Davis, David G. Bruce, and Timothy M. E. Davis
There is consistent evidence that type 2 diabetes is associated with an increased incidence of hip fracture, with a relative risk in meta-analyses of between…

Mortality Among Hospitalized Patients With Hypoglycemia: Insulin Related and Noninsulin Related
JCEM | November 17, 2016
Amit Akirov, Alon Grossman, Tzipora Shochat, and Ilan Shimon
Spontaneous and insulin-related hypoglycemia is common among hospitalized patients with and without diabetes mellitus (DM)…

Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism: A Randomized Controlled Study
JCEM | October 31, 2016
Thozhukat Sathyapalan, Alan S. Rigby, Shalender Bhasin, Natalie J. Thatcher, Eric S. Kilpatrick, and Stephen L. Atkin
Production and consumption of soy foods within Western countries have increased dramatically in the past decade, with the postulated health benefits including…

Diagnosis of ABCC8 Congenital Hyperinsulinism of Infancy in a 20-Year-Old Man Evaluated for Factitious Hypoglycemia
JCEM | October 18, 2016
Amichai Gutgold, David J. Gross, Benjamin Glaser, and Auryan Szalat
A 20-year-old male military paramedic was referred to our emergency department for evaluation of recurrent hypoglycemia episodes. One day before presenting to our hospital…

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study
JCEM | October 12, 2016
Jean-Michel Petit, Jean-Pierre Cercueil, Romaric Loffroy, Damien Denimal, Benjamin Bouillet, Coralie Fourmont, Olivier Chevallier, Laurence Duvillard, and Bruno Vergès
Nonalcoholic fatty liver disease (NAFLD) is commonly associated with type 2 diabetes and increases the risk for the development of nonalcoholic steatohepatitis (NASH), cirrhosis, and…

Autoimmune Diseases in Children and Adults with Type 1 Diabetes from the T1D Exchange Clinic Registry
JCEM | September 27, 2016
Jing W. Hughes, Tonya D. Riddlesworth, Linda A. DiMeglio, Kellee M. Miller, Michael R. Rickels and Janet B. McGill
Type 1 diabetes (T1D) is associated with other autoimmune diseases (AIDs), but the prevalence and associated predictive factors for these comorbidities of T1D across all age groups have not been…

Spontaneous Hypoglycemia after Islet Transplantation: The Case for Using Non-Hepatic Sites
JCEM | September 9, 2016
R. Paul Robertson
This Perspective provides a brief history of intrahepatic alloislet and autoislet transplantation in humans and an update of the recent success rates. It also examines the important role that…

Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans
JCEM | September 7, 2016
Ron T. Varghese, Chiara Dalla Man, Anu Sharma, Ivan Viegas, Cristina Barosa, Catia Marques, Meera Shah, John M. Miles, Robert A. Rizza, John G. Jones, Claudio Cobelli and Adrian Vella
Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. We sought to determine the relative contributions of insulin secretion…

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients with Type 1 Diabetes
JCEM | August 4, 2016
Nitesh D. Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra and Paresh Dandona
It is imperative that novel approaches to treatment of type 1 diabetes (T1D) are devised. The objective of the study was to investigate whether addition of dapagliflozin to insulin and liraglutide…

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults
JCEM | September 2, 2016
Anne L. Peters(chair), Andrew J. Ahmann, Tadej Battelino, Alison Evert, Irl B. Hirsch, M. Hassan Murad, William E. Winter, and Howard Wolpert
Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of…

Diabetes and Pregnancy
JCEM | December 4, 2013
Ian Blumer, Eran Hadar, David R. Hadden, Lois Jovanovič, Jorge H. Mestman, M. Hassan Murad, and Yariv Yogev
Using an evidence-based approach, this Diabetes and Pregnancy Clinical Practice Guideline addresses important clinical issues in the contemporary management of women with type 1 or type 2 diabetes…

Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting
JCEM | July 2, 2013
Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Victor M. Montori, Jane J. Seley, and Greet Van den Berghe
Hyperglycemia is a common, serious, and costly health care problem in hospitalized patients. Observational and randomized controlled studies indicate that improvement in glycemic control results…

Evaluation and Management of Adult Hypoglycemic Disorders
JCEM | April 30, 2011
Philip E. Cryer, Lloyd Axelrod, Ashley B. Grossman, Simon R. Heller, Victor M. Montori, Elizabeth R. Seaquist, and F. John Service
We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad--symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and…

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk
JCEM | January 14, 2009
James L. Rosenzweig, Ele Ferrannini, Scott M. Grundy, Steven M. Haffner, Robert J. Heine, Edward S. Horton, and Ryuzo Kawamori
Healthcare providers should incorporate into their practice concrete measures to reduce the risk of developing CVD and T2DM. These include the regular screening and identification of patients at…

Metabolic Syndrome Bench to Clinic
Dates: March 11, 2017
Location: Baltimore, Maryland, United States
Sponsor: Society of Toxicology

2017 Gordon Research Conference on IGF and Insulin System in Physiology and Disease
Dates: March 12 - 17, 2017
Location: Ventura, California, United States
Sponsor: Gordon Research Conferences

Emerging Trends in Non-Alcoholic Fatty Liver Disease
Dates: March 18-19, 2017
Sponsor: American Association for the Study of Liver Diseases
Location: Washington, DC, United States

Sex and Gender Factors Affecting Metabolic Homeostasis and Diabetes and Obesity
Dates: March 19 - 23, 2017
Location: Tahoe City, California, United States
Sponsor: Keystone Symposia on Molecular and Cellular Biology

16th Global Diabetes Conference and Medicare Expo
Dates: March 22 - 23, 2017
Sponsor: Conference Series LLC
Location: Rome, Italy

ENDO 2017 Preconference
2017 Rachmiel Levine Arthur Riggs Diabetes Research Symposium

Dates: March 28 - 31, 2017
Location: Orlando, Florida, United States
Sponsor: City of Hope

ENDO 2017 Preconference
Endocrine Fellows Series: Type 1 Diabetes Care and Management

Dates: March 29 - 30, 2017
Location: Orlando, Florida, United States
Sponsor: Endocrine Society

ENDO 2017 Preconference
Diabetes Diagnosis & Management 2017

Dates: March 31, 2017
Location: Orlando, Florida, United States
Sponsor: Endocrine Society

Dimensions in Diabetes
Dates: June 17-18, 2017
Sponsor: Endocrine Society
Location: Mumbai, India

19th Asia Pacific Diabetes Conference
Dates: July 20-22, 2017
Sponsor: Conference series LLC
Location: Melbourne, Victoria, Australia

22nd International Congress on Prevention of Diabetes and Complications
Dates: October 12-13, 2017
Sponsor: Conference series LLC
Location: London, England, United Kingdom

Popular Resources